Afrin PDF

Preview

Summary

med card for Afrin...

Description

CLASS: Sympathomimetic

GENERIC NAME: Oxymetazoline

TRADE NAMES: - Afrin - Naphazoline - Phenylephrine - Psuedoepedrine (Sudafed) - Tetrahydrozoline - Xylometazoline MOA: Vasoconstrictor and decongestant actions when applied to nasal mucosa; vasoconstriction of the smaller arterioles of the nasal passages. INDICATIONS: Decreases nasal inflammation and edema by simulating alpha-adrenergic receptors on nasal blood vessels. This ultimately leads to vasoconstriction, which shrinks secretion of nasal tissue and also dries the mucous membrane. CONTRAINDICATIONS/PRECAUTIONS: Allergenic cross-reactivity for drugs in this class is limited but cannot be ruled out with certainty. Concomitant use of MAO-I therapy. Pts with thyroid disorders Hypertension Diabetes Heart disease These pts should use sympathomimetics in directed by provider INTERACTIONS with other Drugs/Substances: - Other sympathomimetics - Additive effects - Herbal supplements such as St. John's Wart - MAOIs - Hypertensive crisis PATIENT RESPONSE / REACTIONS: DESIRED OUTCOME: Decreased nasal inflammation and edema.

COMMON SIDE EFFECTS: Nasal irritation (including sneezing, stinging/burning, runny nose), HA, insomnia, anxiety, rebound nasal congestion, Minor stinging and dryness in nasal mucosa. ASSESS: • - Assess for desired therapeutic effects. • - Assess and instruct patient to report color and

NURSING ACTIONS:

- - Monitor Vital signs: specifically pulse and rhythm (especially when taking decongestants).

ADVERSE REACTIONS: chest pain or pressure, cardiac dysrhythmia, tachycardia, hypertension.

S/S TOXICITY: drowsiness, slow heartbeat, dizziness, fainting.

TOXICITY/OVERDOSE TX:

CARE/IMPLEMENT: • Blow your nose gently. Tilt the head back while standing or sitting up, or lie down on

TEACH:

EVALUATE: Decreased nasal inflammation and edema. Prevention of MI.

- Teach patient to limit use of decongestant nasal sprays to 3-5 days to avoid rebound congestion

- Monitor for dry cough, increasing cough severity, increasing congestion, or dyspnea. - Monitor and instruct patient to report for any decreased CNS effect. - Monitor and instruct patient to report changes in vision.

•

consistency of sputum. - assess for changes in vision.

a bed and hang the head over the side. Place the drops into each nostril and keep the head tilted back for a few minutes to allow the medicine to spread throughout the nose.

- Nasal passages should be cleared by blowing, followed by the nasal spray - Instruct patient to learn forward and have patient be in head-low position to increase the desired effect and to prevent swallowing the medication....